Search Results for "Ranbaxy Launches Atorvastatin In Us"

16:03 EDT 23rd September 2017 | BioPortfolio

Matching Channels


Matching News

Atorvastatin Treatment and Risk of Diabetic Foot Infection

Previous atorvastatin use may help protect against the development of diabetic foot infection among adult patients with diabetes, a new study reports. Wounds

Global and Chinese Atorvastatin Calcium Industry, 2017 Market Research Report [Updated: 21062017] Prices from USD $3000

The 'Global and Chinese Atorvastatin Calcium Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Atorvastatin Calcium industry with a focu...

Global Atorvastatin Calcium Market Data Survey Report 2025 [Report Updated: 09082017] Prices from USD $1500

SummaryAtorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug trade name: Lipitor, which is a prescription medicine that lowers the LDL cholesterol and tr...

Esperion Announces Positive Top-Line Results From Phase II Study Of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin

  Life Sciences Jobs   ...

Pulling away from the pack in drug launches

This analysis of US drug launches from the past decade indicates that commercial success has become more difficult to achieve, owing to factors such as increased competition, greater challenges in ach...

UPS Launches New Shipment Service in Europe for Time-Sensitive Biologics & More

NewsUPS Express Critical service launches in Europe.Contributed Author: 

MSD scores trial success in reducing cardiovascular risk

New data on MSD’s anacetrapib has revealed that the drug was able to reduce risk of the risk of major coronary events by 9% compared to placebo in a study of 30,449 patients suffering atheroscleroti...

CRF Health launches TrialConsent 2.0 Platform 

CRF Health, a global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches version 2 of TrialConsent, offering new enhancements to the industry...

Matching PubMed Articles

Atorvastatin therapy under clinical practice conditions - which LDL-C levels are achieved in patients at very high cardiovascular risk?

Current information on the utilisation of atorvastatin under clinical practice conditions is limited. The cross sectional study DISCOVER documented in the period from June until December 2014 dose and...

Assessment of Response of Kidney Tumors to Rapamycin and Atorvastatin in Tsc1(+/-) Mice.

Atorvastatin is widely used to lower blood cholesterol and to reduce risk of cardiovascular disease-associated complications. Epidemiological investigations and preclinical studies suggest that statin...

Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome.

Objective Compared the effect of atorvastatin 10 mg combined ezetimibe 10 mg therapy with atorvastatin 20 mg on the long-term outcomes in very elderly patients with acute coronary syndrome.Methods A t...

Atorvastatin Can Ameliorate Left Atrial Stunning Induced by Radiofrequency Ablation for Atrial Fibrillation.

The objective of this study was to study the functional changes of left atrium after radiofrequency ablation treatment for atrial fibrillation and the therapeutic effect of Atorvastatin. 58 patients u...

The short term effect of atorvastatin plus ezetimibe therapy vs. atorvastatin monotherapy on clinical outcome in the acute coronary syndrome patients by gender.

Atorvastatin reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe (EZE), a nonstatin drug that reduces intestinal chole...

Search Whole site using Google

Quick Search
Advertisement Advertisement